PolyPid Ltd. (PYPD)
Stock Price:
$13.55 USD
0.55 (4.23%)
Updated Sep 18, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
230.98M |
| Revenue (ttm) |
n/a |
| Net Income (ttm) |
6.91M |
| Shares Out |
17.05M |
| EPS (ttm) |
n/a |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Sep 18, 2020 |
| Last Price |
$13.55 |
| Previous Close |
$13.00 |
| Change ($) |
0.55 |
| Change (%) |
4.23% |
| Day's Open |
13.24 |
| Day's Range |
12.90 - 13.55 |
| Day's Volume |
9,000 |
| 52-Week Range |
10.76 - 19.45 |
More Stats
| Market Cap |
230.98M |
| Enterprise Value |
204.00M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
17.05M |
| Float |
n/a |
| EPS (basic) |
n/a |
| EPS (diluted) |
n/a |
| FCF / Share |
-32.42 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
151,670 |
| Short Ratio |
0.32 |
| Short % of Float |
0.07% |
| Beta |
n/a |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
n/a |
| PB Ratio |
2.72 |
| Revenue |
n/a |
| Operating Income |
-18.56M |
| Net Income |
6.91M |
| Free Cash Flow |
-18.24M |
| Net Cash |
26.98M |
| Net Cash / Share |
1.58 |
| Gross Margin |
n/a |
| Operating Margin |
n/a |
| Profit Margin |
n/a |
| FCF Margin |
n/a |
| ROA |
n/a |
| ROE |
n/a |
| ROIC |
45.80% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (5)
| Buy |
4 |
| Overweight |
1 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$25.80*
(90.41% upside)
Low
22.0
Current: $13.55
High
30.0
Target: 25.80
*Average 12-month price target from 5 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 |
|---|
| Revenue | - | - |
| Operating Income | -18.56 | -18.36 |
| Net Income | 6.91 | -5.92 |
| Shares Outstanding | 0.56 | 0.56 |
| Earnings Per Share | -23.69 | -0.86 |
| Operating Cash Flow | -17.36 | -16.68 |
| Capital Expenditures | -0.88 | -3.07 |
| Free Cash Flow | -18.24 | -19.75 |
| Cash & Equivalents | 26.98 | 7.55 |
| Net Cash / Debt | 26.98 | 7.55 |
| Assets | 33.75 | 14.48 |
| Liabilities | 121 | 96.19 |
| Book Value | -87.63 | -81.71 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
PolyPid Ltd. |
| Country |
Israel |
| Employees |
57 |
| CEO |
Amir Weisberg |
Stock Information
| Ticker Symbol |
PYPD |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Biotechnology |
| Unique Identifier |
NASDAQ: PYPD |
| IPO Date |
June 26, 2020 |
Description
PolyPid Ltd. develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix platform. Its products include D-PLEX, an antibiotic drug reservoir that is implanted during surgery to prevent and treat surgical site infections; D-PLEX100 for the prevention of post-abdominal surgery incisional infection; BONYPID-1000, an antibiotic eluting ß tri-calcium phosphate granule for bone related infections applications; and BONYPID?500, an antibiotic eluting bone graft substitute that fills and reconstructs periodontal and oral/maxillofacial defects, while protecting from infections. PolyPid Ltd. was founded in 2008 and is headquartered in Petach Tikva, Israel. Address: 18 Hasivim Street, Petach Tikva, Israel, 4959376